Valora Therapeutics is a pre-clinical stage biopharmaceutical company developing next-generation multispecific antibodies and T cell engager therapies that decoy the glyco-immune checkpoint to create best-in-class therapeutics for cancer and autoimmune diseases
Valora Therapeutics is a pre-clinical stage biopharmaceutical company developing next-generation multispecific antibodies and T cell engager therapies that decoy the glyco-immune checkpoint to create best-in-class therapeutics for cancer and autoimmune diseases.